API solubility and bioavailability, new technology for pharmaceutical products, twin screw technology, melt granulation and...
EKICART® is a patented nutraceutical for maintaining healthy joints and to support flexible movement.
Ekicart is also used to meet the increased need for nutrients of the musculoskeletal system at high load and in the growth phase.
Ekicart contains a broad spectrum of natural antioxidants that permanently neutralizes the free radicals causing tissue damage. The oxidative stress is reduced and resistance of the cartilage cells is improved.
Ekicart contains free amino acids and glucosamine as basic building blocks in its smallest possible form because the cartilage is fed by synovial fluid through diffusion.
Nanometre sized layers of extracellular matrix are built daily. The extracellular matrix transforms into cartilage with the help of the right co-factors. Where there is wear and tear of cartilage, this leads to recovery.
Ekicart is administered for three months at 50 g/day or one measuring scoop at night in the food. Normal mobility is recovered.
To discuss distribution opportunities, contact Anicur at [email protected]
Open Communication Crucial in Reassembly and Automation of Process Installation for Laboratoria Smeets
Large scale projects do not always exceed the deadline, budget and the stress limitation of...
Labo Smeets Develops Technique for Continuous Production of Water-Soluble Granules Via Twin Screw Granulation
Labo Smeets has developed, in collaboration with Ghent University, a technique to produce water-soluble granules...
New massflow FRS technology 2nd December 2003 - FlexLink is proud to launch the very...